Serum/CSF NfL levels in cohort A were elevated in SCA3 patients, and serum and CSF NfL exhibited a significant positive correlation (r = 0.9179, p < 0.0001). The gene discussed is NEFL; the disease is Spinocerebellar ataxia type 3.